Covered recipient · General Payments record
SIDNEY NELSON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$533.45
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $354.80 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $91.47 | 4 |
| Lilly USA, LLC | $70.79 | 4 |
| Novo Nordisk AS | $41.16 | 2 |
| Abbott Laboratories | $34.60 | 2 |
| Mallinckrodt Hospital Products Inc. | $34.27 | 1 |
| Hologic Sales and Service, LLC | $23.15 | 1 |
| Neos Therapeutics, LP | $20.92 | 1 |
| Medtronic, Inc. | $19.80 | 1 |
| DEXCOM, INC. | $18.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.08 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124804612 | CMS |
| Abbott Laboratories | $17.52 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124804614 | CMS |
| Dexcom, Inc. | $18.64 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153336763 | CMS |
| Hologic Sales and Service, LLC | $23.15 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084919728 | CMS |
| Lilly USA, LLC | $16.05 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428542 | CMS |
| Lilly USA, LLC | $20.46 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135419729 | CMS |
| Lilly USA, LLC | $15.94 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410889 | CMS |
| Lilly USA, LLC | $18.34 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135428544 | CMS |
| Mallinckrodt Hospital Products Inc. | $34.27 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145112542 | CMS |
| Medtronic, Inc. | $19.80 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117033451 | CMS |
| Neos Therapeutics, LP | $20.92 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082667603 | CMS |
| Novo Nordisk Inc | $24.87 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097373071 | CMS |
| Novo Nordisk Inc | $16.29 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573750 | CMS |
| PFIZER INC. | $28.79 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131573193 | CMS |
| PFIZER INC. | $25.91 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131457902 | CMS |
| PFIZER INC. | $14.81 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131489964 | CMS |
| PFIZER INC. | $21.96 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131512756 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.